Xiao Lin Selected Research

Xiao Lin Research Topics

Disease

42	Neoplasms (Cancer) 09/2021 - 06/2003
18	Inflammation (Inflammations) 01/2022 - 10/2013
11	Hypoxia (Hypoxemia) 02/2022 - 04/2012
8	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2014
8	Osteoporosis 01/2022 - 10/2013
8	Migraine Disorders (Migraine) 01/2021 - 02/2011
8	Carcinoma (Carcinomatosis) 01/2020 - 06/2007
7	Ischemia 10/2022 - 01/2010
7	Fibrosis (Cirrhosis) 01/2022 - 01/2017
6	Arthritis (Polyarthritis) 04/2021 - 12/2014
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 10/2002
5	Wounds and Injuries (Trauma) 01/2022 - 01/2017
5	Infections 01/2022 - 01/2017
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 09/2015
5	Lung Neoplasms (Lung Cancer) 04/2021 - 11/2012
5	Carcinogenesis 04/2021 - 10/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2010
5	Schizophrenia (Dementia Praecox) 01/2021 - 01/2017
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 01/2009
4	Infarction (Infarctions) 10/2022 - 11/2016
4	Ischemic Stroke 10/2022 - 01/2019
4	Hyperglycemia 12/2021 - 01/2019
4	Atherosclerosis 01/2021 - 01/2018
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 01/2015
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2019 - 01/2018
4	AIDS-Related Complex (ARC) 10/2018 - 05/2013
4	Osteoarthritis 12/2016 - 09/2014
3	Vascular Calcification 01/2022 - 09/2019
3	Adenocarcinoma of Lung 01/2022 - 11/2012
3	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 01/2020
3	Fatty Liver 12/2021 - 01/2021
3	Chronic Hepatitis B 09/2021 - 01/2021
3	Body Weight (Weight, Body) 09/2021 - 05/2020
3	Insulin Resistance 01/2021 - 03/2015
3	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2018
3	Substance-Related Disorders (Drug Abuse) 01/2018 - 01/2016
3	Nasopharyngeal Carcinoma 01/2018 - 05/2005
3	Neoplasm Metastasis (Metastasis) 12/2017 - 05/2009
2	Stroke (Strokes) 10/2022 - 01/2022
2	Thrombosis (Thrombus) 03/2022 - 01/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2021
2	Myopia 01/2022 - 01/2016
2	COVID-19 01/2022 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 12/2021 - 11/2020
2	Huntington Disease (Huntington's Disease) 11/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2013
13	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2010
11	Biological ProductsIBA 01/2021 - 03/2004
10	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2015
10	Pharmaceutical PreparationsIBA 12/2020 - 01/2016
7	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2016
6	CytokinesIBA 01/2022 - 11/2016
6	LipidsIBA 12/2021 - 01/2018
6	AntioxidantsIBA 03/2017 - 12/2014
5	Histones (Histone)IBA 01/2022 - 04/2011
5	Messenger RNA (mRNA)IBA 12/2021 - 01/2018
5	LDL Receptors (LDL Receptor)IBA 09/2021 - 01/2018
5	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2018
5	AlloysIBA 10/2018 - 05/2013
5	Monoamine Oxidase (MAO)IBA 10/2018 - 05/2013
5	Polysaccharides (Glycans)IBA 11/2016 - 01/2009
4	Oxygen (Dioxygen)IBA 10/2022 - 01/2010
4	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2021
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2002
4	InflammasomesIBA 01/2021 - 01/2018
4	Gallic AcidIBA 12/2016 - 12/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2019
3	Surface Antigens (Surface Antigen)IBA 01/2022 - 04/2021
3	Lysine (L-Lysine)FDA Link 01/2022 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2012
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2021 - 01/2021
3	Immunoglobulins (Immunoglobulin)IBA 06/2021 - 01/2021
3	Insulin (Novolin)FDA Link 01/2021 - 03/2015
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 02/2011
3	CollagenIBA 01/2021 - 01/2016
3	AntigensIBA 01/2021 - 02/2013
3	Phosphates (Orthophosphate)IBA 01/2021 - 01/2018
3	CholesterolIBA 07/2019 - 01/2018
3	Glutamic Acid (Glutamate)FDA Link 01/2019 - 06/2015
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 01/2017
3	RadiopharmaceuticalsIBA 01/2018 - 05/2009
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2016 - 12/2014
3	deoxyglucose dithiocarbamateIBA 08/2014 - 05/2009
3	senkyunolide IIBA 08/2012 - 02/2011
2	Therapeutic UsesIBA 10/2022 - 01/2020
2	HydrogelsIBA 03/2022 - 01/2019
2	SugarsIBA 01/2022 - 01/2022
2	NucleosidesIBA 01/2022 - 09/2021
2	Hepatitis B e AntigensIBA 01/2022 - 09/2021
2	SilicatesIBA 01/2022 - 11/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2017
2	agomelatine (S20098)IBA 12/2021 - 11/2020
2	Mirtazapine (Rexer)FDA LinkGeneric 12/2021 - 11/2020
2	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2021

Therapy/Procedure

23	Therapeutics 01/2021 - 12/2004
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2022 - 01/2010
7	Radiotherapy 03/2022 - 12/2004
7	Drug Therapy (Chemotherapy) 09/2021 - 09/2015
4	Precision Medicine 03/2020 - 12/2018
2	Injections 03/2022 - 01/2019